Guus F Rimmelzwaan
Overview
Explore the profile of Guus F Rimmelzwaan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
220
Citations
13218
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Krammer F, Barclay W, Beer M, Brown I, Cox R, de Jong M, et al.
Lancet Infect Dis
. 2025 Feb;
PMID: 39978373
No abstract available.
2.
Quinones-Parra S, Gras S, Nguyen T, Farenc C, Szeto C, Rowntree L, et al.
Sci Immunol
. 2025 Feb;
10(104):eadn3805.
PMID: 39919196
Cross-reactive αβ T cell receptors (TCRs) recognizing multiple peptide variants can provide effective control of rapidly evolving viruses yet remain understudied. By screening 12 naturally occurring influenza-derived HLA-B*35:01-restricted nucleoprotein (NP)...
3.
Waldock J, Cox R, Engelhardt O, Ascough S, Osterhaus A, Rimmelzwaan G, et al.
Influenza Other Respir Viruses
. 2024 Oct;
18(10):e70013.
PMID: 39440808
Controlled human infection models (CHIMs) are a critical tool for the understanding of infectious disease progression, characterising immune responses to infection and rapid assessment of vaccines or drug treatments. There...
4.
Aregay A, Slunecko J, Bogovic P, Korva M, Rus K, Knap N, et al.
Emerg Microbes Infect
. 2024 Aug;
13(1):2317909.
PMID: 39133062
Tick-borne encephalitis virus (TBEV) infection may cause acute central nervous system inflammation varying in clinical manifestations and severity. A possible correlation of TBEV-specific antibody and cell-mediated immune responses, shortly after...
5.
Aregay A, Slunecko J, Korva M, Bogovic P, Rus K, Knap N, et al.
NPJ Vaccines
. 2024 Aug;
9(1):141.
PMID: 39112523
Tick-borne encephalitis virus (TBEV) vaccine breakthrough (VBT) infections are not uncommon in endemic areas. The clinical and immunological outcomes have been poorly investigated. We assessed the magnitude and specificity of...
6.
Leroux-Roels I, Prajeeth C, Aregay A, Nair N, Rimmelzwaan G, Osterhaus A, et al.
Lancet Infect Dis
. 2024 Jul;
24(11):1245-1253.
PMID: 39068957
Background: Rift Valley fever virus, a pathogen to ruminants, camelids, and humans, is an emerging mosquito-borne bunyavirus currently endemic to Africa and the Arabian Peninsula. Although animals are primarily infected...
7.
Wilken L, Rimmelzwaan G, Elbahesh H
J Virol
. 2024 Jul;
98(8):e0061824.
PMID: 39023323
Importance: There is an urgent need to develop effective therapeutics against re-emerging arboviruses associated with neurological disorders like Zika virus (ZIKV). We identified two FDA-approved kinase inhibitors, Dabrafenib and Regorafenib,...
8.
Prajeeth C, Zdora I, Saletti G, Friese J, Gerlach T, Wilken L, et al.
Emerg Microbes Infect
. 2024 Jul;
13(1):2373313.
PMID: 38946528
Rift Valley fever (RVF) is a mosquito-borne zoonotic disease caused by RVF virus (RVFV). RVFV infections in humans are usually asymptomatic or associated with mild febrile illness, although more severe...
9.
Jansen J, Meineke R, Molle A, van de Sandt C, Saletti G, Rimmelzwaan G
Virus Res
. 2024 Mar;
343:199355.
PMID: 38490580
Influenza viruses are notorious for their capacity to evade host immunity. Not only can they evade recognition by virus-neutralizing antibodies, there is also evidence that they accumulate mutations in epitopes...
10.
Kubinski M, Beicht J, Gerlach T, Aregay A, Osterhaus A, Tscherne A, et al.
Vaccines (Basel)
. 2024 Jan;
12(1).
PMID: 38276677
Tick-borne encephalitis (TBE) is a serious neurological disease caused by TBE virus (TBEV). Because antiviral treatment options are not available, vaccination is the key prophylactic measure against TBEV infections. Despite...